AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 13.34 USD 1.83% Market Closed
Market Cap: 587.1m USD
Have any thoughts about
AxoGen Inc?
Write Note

AxoGen Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AxoGen Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
AxoGen Inc
NASDAQ:AXGN
EPS (Diluted)
$0
CAGR 3-Years
21%
CAGR 5-Years
14%
CAGR 10-Years
9%
Becton Dickinson and Co
NYSE:BDX
EPS (Diluted)
$5
CAGR 3-Years
-5%
CAGR 5-Years
9%
CAGR 10-Years
0%
Boston Scientific Corp
NYSE:BSX
EPS (Diluted)
$1
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
19%
Stryker Corp
NYSE:SYK
EPS (Diluted)
$9
CAGR 3-Years
23%
CAGR 5-Years
1%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
EPS (Diluted)
$3
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
10%
Intuitive Surgical Inc
NASDAQ:ISRG
EPS (Diluted)
$6
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
17%
No Stocks Found

AxoGen Inc
Glance View

Market Cap
587m USD
Industry
Health Care

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.

AXGN Intrinsic Value
9.97 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is AxoGen Inc's EPS (Diluted)?
EPS (Diluted)
-0.3 USD

Based on the financial report for Sep 30, 2024, AxoGen Inc's EPS (Diluted) amounts to -0.3 USD.

What is AxoGen Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
9%

Over the last year, the EPS (Diluted) growth was 41%. The average annual EPS (Diluted) growth rates for AxoGen Inc have been 21% over the past three years , 14% over the past five years , and 9% over the past ten years .

Back to Top